Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock (NQ:RAIN)

2.800 +0.020 (+0.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rain Enhancement Technologies Holdco, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
RAIN EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Rain Oncology Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Rain Oncology Inc. (RAIN) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Rain Oncology Inc. Securities Class Action
From Robbins LLP
Via Business Wire
NASDAQ:RAIN Investor Alert: Investigation over Possible Violations of Securities Laws by Rain Oncology Inc. ↗
San Diego, CA -- (SBWIRE) -- 06/09/2023 -- Rain Oncology Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Analyst Expectations for Rain Oncology's Future ↗
 
Via Benzinga
News headline image
10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More ↗
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
News headline image
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Rain Oncology Inc. (RAIN) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Rain Oncology Inc. (RAIN) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Rain Oncology Inc. (RAIN) Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Rain Oncology Inc. (RAIN)
From Robbins LLP
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 5, 2023 ↗
 
Via Benzinga
News headline image
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
Gainers Better Choice Company Inc. (NASDAQ: BTTR) shares rose 37% to $0.4522 in pre-market trading. Better Choice said it has selected Re:Amaze to assist in customer retention and acquisition for its... 
Via Benzinga
News headline image
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group. 
Via Benzinga
News headline image
Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying ↗
The Dow Jones closed higher by around 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views ↗
Shares of Rain Oncology Inc (NASDAQ: RAIN) recovered in early trading on Tuesday, after having plummeted on disappointing cancer study data. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023 ↗
 
Via Benzinga
News headline image
Why Shares of Rain Oncology Are Plummeting Today ↗
The company released disappointing top-line results for its lead oncology therapy. 
Via The Motley Fool
News headline image
Rain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readout ↗
Rain Oncology Inc (NASDAQ: RAIN) announced topline Phase 3 MANTRA data of milademetan in patients with  
Via Benzinga
News headline image
Dow Tumbles 100 Points; Micron Technology Shares Plunge ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping over 100 points on Monday. The Dow traded down 0.36% to 33,306.30 while the NASDAQ rose 0.39% to 12,707.21. The S&P 500,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.